Exclusive 3D-brachytherapy as a good option for stage-I inoperable endometrial cancer: a retrospective analysis in the gynaecological cancer GEC-ESTRO Working Group.

Ángeles RovirosaYaowen ZhangCyrus ChargariRachel CooperPeter BownesPiotr WojcieszekMagdalena StankiewiczPeter HoskinElzbieta Van der Steen-BanasikBarbara SegedinDina NajjariRichard PötterKari TanderupErik Van Limbergennull nullnull null

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)

Inoperable EC patients can be safely treated by BT with 2 and 5 year CSS of 93 and 80.5%, respectively, with even better results for IA cases. Prospective studies on 3D-IGBT are necessary to better analyse EC patient outcomes based on dose and treated volumes.

Keyphrases

endometrial cancer
newly diagnosed
end stage renal disease
locally advanced
ejection fraction
chronic kidney disease
high dose
radiation therapy
papillary thyroid
peritoneal dialysis
squamous cell carcinoma
low dose
young adults
squamous cell